Trials / Conditions / Phelan-McDermid Syndrome

Phelan-McDermid Syndrome

15 registered clinical trials studyying Phelan-McDermid Syndrome — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome NCT07281079	Neuren Pharmaceuticals Limited	Phase 3
Recruiting	RB001 Gene Therapy Study in Children With SHANK3-related Phelan McDermid Syndrome (PMS) NCT07014020	Peking University First Hospital	N/A
Recruiting	JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency NCT06662188	Jaguar Gene Therapy, LLC	Phase 1 / Phase 2
Completed	An Open-Label Study of Oral NNZ-2591 in Phelan-McDermid Syndrome (PMS-001) NCT05025241	Neuren Pharmaceuticals Limited	Phase 2
Completed	A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism NCT05187377	Icahn School of Medicine at Mount Sinai	Phase 2
Completed	Effectiveness of Recombinant Human Growth Hormone Therapy for Children With PMS NCT05105685	Affiliated Hospital of Jiangnan University	Phase 1 / Phase 2
Completed	Growth Hormone Treatment in Children With Phelan McDermid Syndrome NCT04003207	Swathi Sethuram	Phase 2
Unknown	Q10 Ubiquinol in Autism Spectrum Disorder and in Phelan-McDermid Syndrome. NCT04312152	Antonio Persico	N/A
Enrolling By Invitation	Parent and Infant Inter(X)Action Intervention (PIXI) NCT03836300	RTI International	N/A
Completed	AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy NCT03493607	Alexander Kolevzon	Phase 2
Completed	Mapping the Phenotype in Adults With Phelan-McDermid Syndrome NCT03426059	Boston Children's Hospital	—
Completed	Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome NCT02710084	Alexander Kolevzon	Phase 2
Active Not Recruiting	Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome NCT02461420	Boston Children's Hospital	—
Completed	Mitochondrial Dysfunction in Phelan-McDermid Syndrome NCT02000167	University of Arkansas	—
Completed	Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome) NCT01525901	Icahn School of Medicine at Mount Sinai	Phase 2